Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Application of non-peptide small-molecular compound as MC4R (melanocortin-4 receptor) agonist and specific mutant medicine mate thereof

A compound and mutant technology, applied in the field of drug preparation and application, can solve problems such as cell membrane localization defects, pERK1/2 signal defects, and ligand affinity defects

Inactive Publication Date: 2017-08-08
INST OF ANIMAL SCI & VETERINARY HUBEI ACADEMY OF AGRI SCI
View PDF1 Cites 3 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0003] Most inactive MC4R mutants have varying degrees of defects in cell membrane localization, ligand affinity, cAMP signaling or pERK1 / 2 signaling

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Application of non-peptide small-molecular compound as MC4R (melanocortin-4 receptor) agonist and specific mutant medicine mate thereof
  • Application of non-peptide small-molecular compound as MC4R (melanocortin-4 receptor) agonist and specific mutant medicine mate thereof
  • Application of non-peptide small-molecular compound as MC4R (melanocortin-4 receptor) agonist and specific mutant medicine mate thereof

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0025] Example 1 Basic preparation example

[0026] The present invention selects commercial plasmid pcDNA3.1(+) (purchased from Clontech Company) as an expression vector, and constructs an expression vector of wild-type (WT) human MC4R (hMC4R): pcDNA3.1-hMC4R-WT. That is, an expression sequence (NM_005912.2) encoding the wild-type hMC4R gene was inserted into the multiple cloning site of pcDNA3.1(+).

[0027] The present invention uses the constructed pcDNA3.1-hMC4R-WT as a template, and utilizes a rapid site-directed mutagenesis kit (purchased from Stratagene) to construct 20 genes named N62S, I69R, P78L, C84R, G98R, Y157S, M161T, W174C, P260Q, C271Y, G55V, Δ88-92, I102T, L106P, D126Y, A219V, D90N, S136F, A175T, C326R Functionally identified expression vectors for the second, third and fourth types of MC4R mutants.

[0028]In the present invention, human kidney embryonic cells (HEK293T) not expressing MC4R receptors are used as a transient expression system for MC4R and mut...

Embodiment 2

[0031] Example 2 Detection of affinity between BMS-470539 and MC1R, MC3R, MC4R, MC5R

[0032] Before HEK293T cells were collected, the cells were washed twice with serum-free medium (purchased from Gibco), and different final concentrations (10 -10 ~10 -5 M) Ligand BMS-470539 (purchased from Bachem Company) and 100,000 cpm radiolabeled ligand 125 HEK293T cells (purchased from ATCC) transfected with MC1R, MC3R, MC4R and MC5R were co-incubated with I-NDP-MSH (purchased from the Peptide Radioactive Iodine Labeling Service Center of the University of Mississippi) (50 μL) at 37°C for 1 h, and after the reaction was terminated, Pre-cooled phosphate buffered saline (PBS (137mM NaCl, 2.7mM KCl, 1.4mM KH 2 PO 4 , 4.3 mM Na 2 HPO 4 , pH 7.4) to wash away unbound markers, add 100 μL of 0.5N NaOH to collect the cells, and use a gamma scintillation counter to measure the amount of receptor-bound cells in the cells 125 The total amount of I-NDP-MSH, that is, the binding ability of MC1...

Embodiment 3

[0037] Example 3 Detection of the ability of BMS-470539 to induce MC1R, MC3R, MC4R and MC5R to produce signal molecule cAMP

[0038] Before HEK293T cells were collected, the cells were washed twice with serum-free medium, and the serum-free medium (purchased from Gibco) containing 0.5 mM isobutylmethylxanthine was incubated at 37°C for transfected MC1R, MC3R, HEK293T cells of MC4R and MC5R for 15min, and then different final concentrations (10 -10 ~10 -5 M) The cells were stimulated with BMS-470539, incubated at 37°C for 1 hour, put the cell culture plate on ice, discarded the culture medium, added 0.5N perchloric acid containing 180 μg / mL theophylline to extract intracellular cAMP, and used radiation Immunoassay (RIA) method 22 The dose-dependent determination of the signal molecule cAMP was carried out, and its effective intermediate concentration (EC 50 ) and the maximum concentration value (R max ).

[0039] The measurement results of this example are consistent with ...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention belongs to the technical fields of medicine preparation and applications, and in particular relates to an application of a non-peptide small-molecular compound as an MC4R (melanocortin-4 receptor) agonist and a specific mutant medicine mate thereof. According to the invention, the on-peptide small-molecular compound is discovered for the first time, wherein the on-peptide small-molecular compound is numbered as BMS470539, chemical name of the on-peptide small-molecular compound is 1-[1-(3-methyl-L-histidyl-O-methyl-D-tyrosyl)-4-phenyl-4-piperidyl]-1-butanone; and molecular weight of the compound is 559.697. The compound, as the melanocortin-4 receptor agonist, can function as the medicine mate to promote recovery of some MC4R defective mutants' capacities of generating signal molecules.

Description

technical field [0001] The invention relates to the technical field of drug preparation and application, in particular to the application of non-peptide small molecule compounds as MC4R agonists and drug partners of specific mutants thereof. The non-peptide small molecule compound is named BMS-470539, and BMS-470539 is used as an application in the preparation of MC4R agonists and specific MC4R mutant drug partners. Background technique [0002] The melanocortin receptor family includes 5 G protein-coupled receptors with different physiological functions (melanocortin receptor 1-5) 1 . Melanocortin receptor-1 mainly plays a role in the pigmentation and anti-inflammation of melanocytes, melanocortin receptor-2 mainly plays a role in steroidogenesis, melanocortin receptor-3 mainly plays a role in feed intake efficiency and nutrient distribution, melanocortin receptor Receptor-4 mainly regulates food intake and energy regulation, while melanocortin receptor-5 acts on exocrine...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): A61K38/05A61P3/04C07K5/078
CPCA61K38/05C07K5/06147
Inventor 熊琪陈明新李晓锋索效军张年杨前平陶虎刘洋田宏张鹤山熊军波
Owner INST OF ANIMAL SCI & VETERINARY HUBEI ACADEMY OF AGRI SCI
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com